Calidi Biotherapeutics is a clinical-stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer.
Calidi Biotherapeutics is a clinical-stage immuno-oncology company with proprietary technology that is revolutionizing the utilization of oncolytic viruses through an allogeneic cell-based delivery system.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Jan 21, 2020 | Convertable Note | $8.17M | 2 | — | — | Detail |
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
Nov 16, 2022
Virtualness
|
Seed | $8M | Information Technology | — |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Greentable Co., Ltd. | — | Convertable Note |
Won & Partners | — | Convertable Note |